800 related articles for article (PubMed ID: 32685002)
41. Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages.
Ye J; Yang Y; Dong W; Gao Y; Meng Y; Wang H; Li L; Jin J; Ji M; Xia X; Chen X; Jin Y; Liu Y
Int J Nanomedicine; 2019; 14():3203-3220. PubMed ID: 31118632
[No Abstract] [Full Text] [Related]
42. Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages.
Kim SH; Saeidi S; Zhong X; Gwak SY; Muna IA; Park SA; Kim SH; Na HK; Joe Y; Chung HT; Kim KE; Han W; Surh YJ
Neoplasia; 2020 Nov; 22(11):606-616. PubMed ID: 33039895
[TBL] [Abstract][Full Text] [Related]
43. Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.
Wanderley CW; Colón DF; Luiz JPM; Oliveira FF; Viacava PR; Leite CA; Pereira JA; Silva CM; Silva CR; Silva RL; Speck-Hernandez CA; Mota JM; Alves-Filho JC; Lima-Junior RC; Cunha TM; Cunha FQ
Cancer Res; 2018 Oct; 78(20):5891-5900. PubMed ID: 30104241
[TBL] [Abstract][Full Text] [Related]
44. Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function.
Grugan KD; McCabe FL; Kinder M; Greenplate AR; Harman BC; Ekert JE; van Rooijen N; Anderson GM; Nemeth JA; Strohl WR; Jordan RE; Brezski RJ
J Immunol; 2012 Dec; 189(11):5457-66. PubMed ID: 23105143
[TBL] [Abstract][Full Text] [Related]
45. TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.
Lee C; Kim S; Jeong C; Cho I; Jo J; Han IH; Bae H
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216272
[TBL] [Abstract][Full Text] [Related]
46. Macrophages are recruited to hypoxic tumor areas and acquire a pro-angiogenic M2-polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin.
Tripathi C; Tewari BN; Kanchan RK; Baghel KS; Nautiyal N; Shrivastava R; Kaur H; Bhatt ML; Bhadauria S
Oncotarget; 2014 Jul; 5(14):5350-68. PubMed ID: 25051364
[TBL] [Abstract][Full Text] [Related]
47. Antagonizing Integrin β3 Increases Immunosuppression in Cancer.
Su X; Esser AK; Amend SR; Xiang J; Xu Y; Ross MH; Fox GC; Kobayashi T; Steri V; Roomp K; Fontana F; Hurchla MA; Knolhoff BL; Meyer MA; Morgan EA; Tomasson JC; Novack JS; Zou W; Faccio R; Novack DV; Robinson SD; Teitelbaum SL; DeNardo DG; Schneider JG; Weilbaecher KN
Cancer Res; 2016 Jun; 76(12):3484-95. PubMed ID: 27216180
[TBL] [Abstract][Full Text] [Related]
48. XIAOPI formula inhibits the pre-metastatic niche formation in breast cancer via suppressing TAMs/CXCL1 signaling.
Zheng Y; Wang N; Wang S; Yang B; Situ H; Zhong L; Lin Y; Wang Z
Cell Commun Signal; 2020 Mar; 18(1):48. PubMed ID: 32213179
[TBL] [Abstract][Full Text] [Related]
49. Breast cancer-associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells.
Gómez V; Eykyn TR; Mustapha R; Flores-Borja F; Male V; Barber PR; Patsialou A; Green R; Panagaki F; Li CW; Fruhwirth GO; Ros S; Brindle KM; Ng T
Sci Signal; 2020 Oct; 13(652):. PubMed ID: 33023985
[TBL] [Abstract][Full Text] [Related]
50. Anti-angiogenesis therapy in the Vx2 rabbit cancer model with a lipase-cleavable Sn 2 taxane phospholipid prodrug using α(v)β₃-targeted theranostic nanoparticles.
Pan D; Schmieder AH; Wang K; Yang X; Senpan A; Cui G; Killgore K; Kim B; Allen JS; Zhang H; Caruthers SD; Shen B; Wickline SA; Lanza GM
Theranostics; 2014; 4(6):565-78. PubMed ID: 24723979
[TBL] [Abstract][Full Text] [Related]
51. A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy.
Pan D; Kim B; Hu G; Gupta DS; Senpan A; Yang X; Schmieder A; Swain C; Wickline SA; Tomasson MH; Lanza GM
Nanomedicine (Lond); 2015 Jan; 10(2):241-51. PubMed ID: 25600969
[TBL] [Abstract][Full Text] [Related]
52. Spatial Targeting of Tumor-Associated Macrophages and Tumor Cells with a pH-Sensitive Cluster Nanocarrier for Cancer Chemoimmunotherapy.
Shen S; Li HJ; Chen KG; Wang YC; Yang XZ; Lian ZX; Du JZ; Wang J
Nano Lett; 2017 Jun; 17(6):3822-3829. PubMed ID: 28488871
[TBL] [Abstract][Full Text] [Related]
53. Breast cancer cells promote CD169
Jing W; Guo X; Wang G; Bi Y; Han L; Zhu Q; Qiu C; Tanaka M; Zhao Y
Int Immunopharmacol; 2020 Jan; 78():106012. PubMed ID: 31865052
[TBL] [Abstract][Full Text] [Related]
54. Selective targeting of tumor associated macrophages in different tumor models.
Kakoschky B; Pleli T; Schmithals C; Zeuzem S; Brüne B; Vogl TJ; Korf HW; Weigert A; Piiper A
PLoS One; 2018; 13(2):e0193015. PubMed ID: 29447241
[TBL] [Abstract][Full Text] [Related]
55. Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer.
Binnemars-Postma K; Bansal R; Storm G; Prakash J
FASEB J; 2018 Feb; 32(2):969-978. PubMed ID: 29066614
[TBL] [Abstract][Full Text] [Related]
56. Reprograming of Tumor-Associated Macrophages in Breast Tumor-Bearing Mice under Chemotherapy by Targeting Heme Oxygenase-1.
Kim SH; Kim SJ; Park J; Joe Y; Lee SE; Saeidi S; Zhong X; Kim SH; Park SA; Na HK; Chung HT; Surh YJ
Antioxidants (Basel); 2021 Mar; 10(3):. PubMed ID: 33809707
[TBL] [Abstract][Full Text] [Related]
57. Baohuoside i suppresses breast cancer metastasis by downregulating the tumor-associated macrophages/C-X-C motif chemokine ligand 1 pathway.
Wang S; Wang N; Huang X; Yang B; Zheng Y; Zhang J; Wang X; Lin Y; Wang Z
Phytomedicine; 2020 Nov; 78():153331. PubMed ID: 32911383
[TBL] [Abstract][Full Text] [Related]
58. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.
Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY
Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336
[TBL] [Abstract][Full Text] [Related]
59. Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line.
Moradi-Chaleshtori M; Bandehpour M; Heidari N; Mohammadi-Yeganeh S; Mahmoud Hashemi S
Int Immunopharmacol; 2021 Jan; 90():107198. PubMed ID: 33249048
[TBL] [Abstract][Full Text] [Related]
60. Sialic acid-targeted cyclodextrin-based nanoparticles deliver CSF-1R siRNA and reprogram tumour-associated macrophages for immunotherapy of prostate cancer.
Sun Y; Cronin MF; Mendonça MCP; Guo J; O'Driscoll CM
Eur J Pharm Sci; 2023 Jun; 185():106427. PubMed ID: 36948408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
